FTSE 100 live: London markets flat despite inflation boost, miners rise Markets Markets were also given a lift by the news that shop price inflation slowed to 2.5 per cent in February, the lowest level seen in two years.
Smith and Nephew lifts outlook as medical device revenue growth offsets China slowdown industrials It wasn't all plain sailing for the medical tech giant however, with its operating profit for the year down to £335m, from £356m.
Sports medicine boosts Smith & Nephew results as chief financial officer steps down Smith & Nephew Medical device manufacturer Smith & Nephew has reported revenue and profit increases due to higher demand for sports medicines as the chief financial officer steps down. Strong performance in sports medicine, advanced wound management, and orthopaedics, which together make up 60 per cent of their business, has led to a 7.3 per cent rise in [...]
Churchill’s grandson and Serco chief named new chair of Smith & Nephew February 17, 2023 The grandson of Sir Winston Churchill and chief executive of Serco has been unveiled as the new chair of 167-year-old medical tech firm Smith & Nephew. Rupert Soames will assume the position at the London-listed company following the retirement of Roberto Quarta, the firm announced. He will take the reins in late September, after joining [...]
Smith & Nephew CEO to leave after salary spat, hitting share price October 21, 2019 Medical device manufacturer Smith & Nephew’s chief executive has announced his departure “by mutual agreement” with the board amid reports he was unhappy with his pay. Namal Nawana will be replaced by former Roche Diagnostics chief Roland Diggelman after just 18 months in the role, sending shares tumbling eight per cent to 1,683p. Read more: [...]
Smith & Nephew share price tilts south as medical giant pulls hip device June 4, 2015 Medical device manufacturer Smith & Nephew was forced to announce its plans to withdraw one of its hip-replacement systems as it required too many post-operative follow-ups. The 46mm model in question will be withdrawn from its Birmingham Hip Resurfacing system due to concerns it does not meet the standards set by health watchdog, Nice. [...]
Smith & Nephew share price soars 8pc on Stryker takeover reports December 24, 2014 Shares in medical equipment group Smith & Nephew surged eight per cent this morning, valuing the business at £10.4bn on the back of reports of a possible takeover by US group Stryker. Stryker, a US surgical implants manufacturer, denied it has any intention to buy the company back in May. However, Last month, it was [...]
Stryker deal talk boosts Smith & Nephew share price November 24, 2014 US-based medical device company Stryker is reportedly examining the purchase of Smith & Nephew, the British manufacturer of surgical devices for orthopaedic construction. Yesterday Smith & Nephew’s stock jumped 4.4 per cent to 1,138p. The news came despite Stryker denying in May that it had any intention of making a bid for Smith & Nephew. [...]
US Zimmer deal boosts Smith & Nephew shares April 24, 2014 SHARES in Smith & Nephew jumped over three per cent yesterday following the buy-out of a group that tried to buy the British health firm back in 2011. New York-listed Zimmer revealed that it is snapping up rival US orthopaedic company Biomet for $13.35bn (£7.95bn). The deal has added more weight to a widely-held view [...]
Smith & Nephew hit by rejection October 28, 2005 Europe’s largest seller of orthopaedic devices saw its shares tumble to a two-year low after it abandoned producing a key leg ulcer treatment when America turned it down, but its sales are up. Smith & Nephew has abandoned production of a key leg ulcer treatment after it failed to win approval for the American market. [...]